BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36441024)

  • 1. TFEB acetylation promotes lysosome biogenesis and ameliorates Alzheimer's disease-relevant phenotypes in mice.
    Li T; Yin L; Kang X; Xue W; Wang N; Zhang J; Yuan P; Lin L; Li Y
    J Biol Chem; 2022 Dec; 298(12):102649. PubMed ID: 36441024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gypenoside XVII Enhances Lysosome Biogenesis and Autophagy Flux and Accelerates Autophagic Clearance of Amyloid-β through TFEB Activation.
    Meng X; Luo Y; Liang T; Wang M; Zhao J; Sun G; Sun X
    J Alzheimers Dis; 2016 Apr; 52(3):1135-50. PubMed ID: 27060963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the dopamine transporter promotes lysosome biogenesis and ameliorates Alzheimer's disease-like symptoms in mice.
    Yin L; Zhou J; Li T; Wang X; Xue W; Zhang J; Lin L; Wang N; Kang X; Zhou Y; Liu H; Li Y
    Alzheimers Dement; 2023 Apr; 19(4):1343-1357. PubMed ID: 36130073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis.
    Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Tripoli DL; Czerniewski L; Ballabio A; Cirrito JR; Diwan A; Lee JM
    J Neurosci; 2015 Sep; 35(35):12137-51. PubMed ID: 26338325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia.
    Bao J; Zheng L; Zhang Q; Li X; Zhang X; Li Z; Bai X; Zhang Z; Huo W; Zhao X; Shang S; Wang Q; Zhang C; Ji J
    Protein Cell; 2016 Jun; 7(6):417-33. PubMed ID: 27209302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of TFEB acetylation in control of its transcriptional activity and lysosomal function in response to histone deacetylase inhibitors.
    Zhang J; Wang J; Zhou Z; Park JE; Wang L; Wu S; Sun X; Lu L; Wang T; Lin Q; Sze SK; Huang D; Shen HM
    Autophagy; 2018; 14(6):1043-1059. PubMed ID: 30059277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetyltransferase GCN5 regulates autophagy and lysosome biogenesis by targeting TFEB.
    Wang Y; Huang Y; Liu J; Zhang J; Xu M; You Z; Peng C; Gong Z; Liu W
    EMBO Rep; 2020 Jan; 21(1):e48335. PubMed ID: 31750630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TFEB Participates in the Aβ-Induced Pathogenesis of Alzheimer's Disease by Regulating the Autophagy-Lysosome Pathway.
    Zhang YD; Zhao JJ
    DNA Cell Biol; 2015 Nov; 34(11):661-8. PubMed ID: 26368054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis.
    Wang S; Ni HM; Chao X; Wang H; Bridges B; Kumer S; Schmitt T; Mareninova O; Gukovskaya A; De Lisle RC; Ballabio A; Pacher P; Ding WX
    Autophagy; 2019 Nov; 15(11):1954-1969. PubMed ID: 30894069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LYECs: lysosome-enhancing compounds as potential therapeutic approaches for Alzheimer disease.
    Yin L; Zhou Y; Liu H; Li Y
    Autophagy; 2023 Jun; 19(6):1863-1864. PubMed ID: 36215390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing astrocytic lysosome biogenesis facilitates Aβ clearance and attenuates amyloid plaque pathogenesis.
    Xiao Q; Yan P; Ma X; Liu H; Perez R; Zhu A; Gonzales E; Burchett JM; Schuler DR; Cirrito JR; Diwan A; Lee JM
    J Neurosci; 2014 Jul; 34(29):9607-20. PubMed ID: 25031402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease.
    Wang X; Xie Y; Chen G; Lu Y; Wang D; Zhu L
    J Neuroinflammation; 2023 Oct; 20(1):240. PubMed ID: 37864249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications.
    Gu Z; Cao H; Zuo C; Huang Y; Miao J; Song Y; Yang Y; Zhu L; Wang F
    Neurobiol Dis; 2022 Oct; 173():105855. PubMed ID: 36031168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Transcription Factor EB Reduces the Intraneuronal Accumulation of the Beta-Secretase-Derived APP Fragment C99 in Cellular and Mouse Alzheimer’s Disease Models.
    Bécot A; Pardossi-Piquard R; Bourgeois A; Duplan E; Xiao Q; Diwan A; Lee JM; Lauritzen I; Checler F
    Cells; 2020 May; 9(5):. PubMed ID: 32408680
    [No Abstract]   [Full Text] [Related]  

  • 15. Trehalose causes low-grade lysosomal stress to activate TFEB and the autophagy-lysosome biogenesis response.
    Jeong SJ; Stitham J; Evans TD; Zhang X; Rodriguez-Velez A; Yeh YS; Tao J; Takabatake K; Epelman S; Lodhi IJ; Schilling JD; DeBosch BJ; Diwan A; Razani B
    Autophagy; 2021 Nov; 17(11):3740-3752. PubMed ID: 33706671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corynoxine promotes TFEB/TFE3-mediated autophagy and alleviates Aβ pathology in Alzheimer's disease models.
    Guan XJ; Deng ZQ; Liu J; Su CF; Tong BC; Zhu Z; Sreenivasmurthy SG; Kan YX; Lu KJ; Chu CP; Pi RB; Cheung KH; Iyaswamy A; Song JX; Li M
    Acta Pharmacol Sin; 2024 May; 45(5):900-913. PubMed ID: 38225393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
    Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
    Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring TFEB translocation.
    Chen G; Mu C; Chen Y; An N; Zhu Y; Kepp O; Kroemer G
    Methods Cell Biol; 2021; 164():1-9. PubMed ID: 34225908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual and emerging role of physical exercise-induced TFEB activation in the protection against Alzheimer's disease.
    Morais GP; de Sousa Neto IV; Marafon BB; Ropelle ER; Cintra DE; Pauli JR; Silva ASRD
    J Cell Physiol; 2023 May; 238(5):954-965. PubMed ID: 37013375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
    Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
    Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.